We Love Fitness

zelboraf may double survival for some melanoma patients

The newly approved drug Zelboraf appears to nearly double the length of time a person can expect to live with advanced melanoma skin cancer, a new study shows.


Home

 Articles & News
We Love Fitness - 2013